
Pipratru 4000mg/500mg Injection
Marketer
Medfe
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Pipratru 4000mg/500mg Injection
Combiflox 4000mg/500mg injection is a dual-antibiotic formulation indicated for diverse bacterial infections. Its mechanism involves microbial eradication. Administration should exclusively be performed by a qualified healthcare provider; self-injection is strictly prohibited. Dosage and frequency are determined by your physician based on individual disease severity, always adhering to the prescribed regimen. Potential side effects encompass nausea, vomiting, diarrhea, and skin rashes; injection site reactions such as pain, swelling, or erythema may also occur. Persistent or worsening side effects necessitate immediate medical consultation. Prior to commencing treatment, disclose any antibiotic allergies, hepatic or renal impairments to your doctor; dose adjustments or alternative therapies may be necessary. Under medical guidance, this medication is generally considered safe for pregnant and lactating individuals.
Uses of Pipratru 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Pipratru 4000mg/500mg Injection:
Administering this medication will be handled by your healthcare provider; self-medication is strongly discouraged.
Common Side effects of Pipratru 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Pipratru 4000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Pipratru 4000mg/500mg Injection works:
Pipratru Injection (4000mg/500mg) combines piperacillin, a bacterial cell wall synthesis inhibitor antibiotic, with tazobactam, a beta-lactamase inhibitor. Tazobactam's action safeguards piperacillin's effectiveness by neutralizing bacterial enzymes that would otherwise break it down, thus broadening its antibacterial spectrum.
SAFETY ADVICE
AlcoholSAFE
Pipratru 4000mg/500mg Injection's concurrent use with alcohol presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Pipratru, 4000mg/500mg, is typically deemed safe for pregnant individuals. Preclinical trials using animals revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human studies remain scarce.
Breast feedingSAFE IF PRESCRIBED
The 4000mg/500mg Pipratru injection presents minimal breastfeeding risk. Research in humans indicates negligible transfer to breast milk, posing no apparent danger to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Pipratru 4000mg/500mg Injection on driving ability is undetermined. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should use Pipratru 4000mg/500mg Injection cautiously. Dosage modification of Pipratru 4000mg/500mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Pipratru 4000mg/500mg Injection in individuals with hepatic impairment is likely safe. Preliminary evidence indicates dose modification may be unnecessary; however, medical advice is recommended.
What if you forget to take Pipratru 4000mg/500mg Injection :
Should you forget a scheduled Pipratru 4000mg/500mg Injection, seek medical advice immediately.
Facts to Know About Pipratru 4000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
